Lyka Labs (BOM:500259) EBIT per Share : ₹1.21 (TTM As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Lyka Labs EBIT per Share?

Lyka Labs's EBIT per Share for the three months ended in Mar. 2024 was ₹-0.14. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.21.

During the past 12 months, the average EBIT per Share Growth Rate of Lyka Labs was -1.70% per year. During the past 3 years, the average EBIT per Share Growth Rate was -38.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Lyka Labs's EBIT per Share or its related term are showing as below:

BOM:500259' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -55 Med: -35.45 Max: 8.9
Current: -38.3

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Lyka Labs was 8.90% per year. The lowest was -55.00% per year. And the median was -35.45% per year.

BOM:500259's 3-Year EBIT Growth Rate is ranked worse than
86.09% of 1301 companies
in the Biotechnology industry
Industry Median: 3.4 vs BOM:500259: -38.30

Lyka Labs's EBIT for the three months ended in Mar. 2024 was ₹-6 Mil.

Lyka Labs EBIT per Share Historical Data

The historical data trend for Lyka Labs's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs EBIT per Share Chart

Lyka Labs Annual Data

Trend

Jun14

Jun15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

-7.10

4.11

27.67

-0.46

1.26

Lyka Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-0.05	-0.14	0.13	1.36	-0.14

Lyka Labs EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Lyka Labs's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	39.572	/	31.509
=	1.26

Lyka Labs's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-5.554	/	38.846
=	-0.14

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.21

Lyka Labs (BOM:500259) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Lyka Labs EBIT per Share Related Terms

Thank you for viewing the detailed overview of Lyka Labs's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lyka Labs (BOM:500259) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (BOM:500259) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

LYKALABS:India

Address

30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036

Website

http://www.lykalabs.com

Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment viz. pharmaceuticals. The Company has presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs (BOM:500259) Headlines

No Headlines